Radon Exposure Linked to CHIP Risk for Women With Ischemic Stroke
By Elana Gotkine HealthDay Reporter
THURSDAY, Jan. 4, 2024 -- Radon exposure is associated with an increased risk for clonal hematopoiesis of indeterminate potential (CHIP) among postmenopausal women with ischemic stroke, according to a study published online Jan. 3 in Neurology.
Kurtis M. Anthony, M.P.H., from the Gillings School of Global Public Health at the University of North Carolina in Chapel Hill, and colleagues estimated the risk for CHIP related to radon by linking geocoded addresses of 10,799 Women's Health Initiative Trans-Omics for Precision Medicine participants to U.S. Environmental Protection Agency-predicted, county-level, indoor average screening radon concentrations, categorized as zones 1, 2, and 3 (>4, 2 to 4, and <2 pCi/L, respectively). CHIP was defined as the presence of one or more leukemogenic driver mutations with variant allele frequency >0.02.
The researchers found that 9.0, 8.4, and 7.7 percent of participants had CHIP in zones 1, 2, and 3, respectively. Zones 2 and 1 were associated with a higher estimated risk for CHIP relative to zone 3 among participants with ischemic stroke (1.39 and 1.46, respectively), but not among those with hemorrhagic stroke or those without stroke. Among Trial of ORG 10172 in Acute Stroke Treatment subtyped cardioembolism or other ischemic etiologies, the corresponding estimates were particularly high, but estimates were not significantly increased for small vessel occlusion.
"In conclusion, although the results do not support an association between radon and CHIP among postmenopausal women overall, they do suggest an association between radon and CHIP among participants with ischemic stroke," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
ASCO: Conjugated Equine Estrogen May Increase Risk for Ovarian Cancer
TUESDAY, May 28, 2024 -- Conjugated equine estrogen (CEE) taken alone for menopause may increase the risk for developing and dying from ovarian cancer, according to a study...
Extreme Temperatures Linked to Increased Risk for Stroke Death
FRIDAY, May 24, 2024 -- Extreme cold and hot temperatures are associated with an increased risk for death from ischemic and hemorrhagic strokes, according to a study published...
Nationwide Prevalence of Stroke Up From 2011-2013 to 2020-2022
THURSDAY, May 23, 2024 -- The prevalence of stroke increased from 2011-2013 to 2020-2022, according to research published in the May 23 issue of the U.S. Centers for Disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.